D. Vergidis
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Genetics 3
- Hemoglobinopathies and Related Disorders 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Andrew W. Maksymiuk (2 shared papers)Yvon Cormier (2 shared papers)Mary A. Davis (2 shared papers)Denis Soulières (2 shared papers)Charles Butts (2 shared papers)Janine Mansi (1 shared paper)Glenwood Goss (1 shared paper)Allan Price (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Vaccine (1 paper)Canadian Journal of Physiology and Pharmacology (1 paper)The Journal of Experimental Medicine (1 paper)International Journal of Circumpolar Health (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
D. Vergidis
11 papers receiving 384 citations
Peers
Comparison fields: 5 of 48
- Immunology 252
- Oncology 235
- Biotechnology 29
- Pulmonary and Respiratory Medicine 91
- Molecular Biology 144
Countries citing papers authored by D. Vergidis
This map shows the geographic impact of D. Vergidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vergidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vergidis more than expected).
Fields of papers citing papers by D. Vergidis
This network shows the impact of papers produced by D. Vergidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vergidis. The network helps show where D. Vergidis may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Vergidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 332 | |
| 2 | 2010 | 23 | |
| 3 | 2009 | 13 | |
| 4 | 2012 | 11 | |
| 5 | 2001 | 6 | |
| 6 | 1982 | 5 | |
| 7 | 2021 | 3 | |
| 8 | 2016 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2013 | 1 | |
| 11 | 2004 | 1 |
About D. Vergidis
D. Vergidis is a scholar working on Genetics, Immunology, Molecular Biology, Oncology and Epidemiology, having authored 11 papers that have together received 398 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Immunotherapy and Immune Responses (2 papers), Eosinophilic Disorders and Syndromes (1 paper), Meningioma and schwannoma management (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Cancer Treatment and Pharmacology (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Immunology (252 citations), Oncology (235 citations), Biotechnology (29 citations), Pulmonary and Respiratory Medicine (91 citations) and Molecular Biology (144 citations). D. Vergidis has collaborated with scholars based in Canada and United States. Frequent co-authors include Andrew W. Maksymiuk, Yvon Cormier, Mary A. Davis, Denis Soulières, Charles Butts, Janine Mansi, Glenwood Goss, Allan Price, Nevin Murray and Martin Palmer. Their work appears in journals such as Journal of Clinical Oncology, Vaccine, Canadian Journal of Physiology and Pharmacology, The Journal of Experimental Medicine and International Journal of Circumpolar Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.